Tenapanor Approved in China for Hyperphosphatemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. SPY
2. USO
3. META
4. MSFT
5. MU
6. COST
7. IONS
8. RXT
9. AAPL
10. CME

Go back to Tenapanor Approved in China for Hyperphosphatemia
Oppenheimer Rising Dividends Fund, Inc. Class A (NASDAQ: ARDX) Delayed: 5.38 -0.05 (0.92%)
Previous Close $5.43    52 Week High $20.98 
Open $5.43    52 Week Low $6.36 
Day High $5.45    P/E N/A 
Day Low $5.33    EPS $0.00 
Volume 2,171,549